These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7116756)
61. Renal function and hemodynamics during treatment with enalapril in primary hypertension. Bauer JH; Reams G; Gaddy P Nephron; 1986; 44 Suppl 1():83-6. PubMed ID: 3018603 [TBL] [Abstract][Full Text] [Related]
62. The influence of diltiazem and nifedipine on renal function in the rat. Johns EJ Br J Pharmacol; 1985 Mar; 84(3):707-13. PubMed ID: 3986432 [TBL] [Abstract][Full Text] [Related]
63. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure. Hannedouche T; Brouard R; Godin M; Kleinknecht D; Paillard F; Grünfeld JP Nephrol Dial Transplant; 1991; 6(4):252-6. PubMed ID: 1679214 [TBL] [Abstract][Full Text] [Related]
64. Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats. Gellai M; DeWolf R; Ruffolo RR Pharmacology; 1990; 41(4):200-6. PubMed ID: 2080230 [TBL] [Abstract][Full Text] [Related]
65. Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo. Thuesen AD; Andersen H; Cardel M; Toft A; Walter S; Marcussen N; Jensen BL; Bie P; Hansen PB Am J Physiol Renal Physiol; 2014 Aug; 307(4):F445-52. PubMed ID: 24966091 [TBL] [Abstract][Full Text] [Related]
66. Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction. Motwani JG; Fenwick MK; Struthers AD Eur Heart J; 1992 Sep; 13(9):1195-200. PubMed ID: 1396829 [TBL] [Abstract][Full Text] [Related]
71. The avian renal portal system: a model for studying nephrotoxicity of xenobiotics. Blackburn R; Prashad D Toxicol Lett; 1990 Sep; 53(1-2):219-21. PubMed ID: 2219172 [No Abstract] [Full Text] [Related]
73. Pharmacokinetics of piroximone after oral and intravenous administration to patients with renal insufficiency. Fauvel JP; Bernard N; Laville M; Pozet N; Sassard J; Zech PY Br J Clin Pharmacol; 1995 Feb; 39(2):187-9. PubMed ID: 7742160 [TBL] [Abstract][Full Text] [Related]
74. Tetraethylammonium as a probe for estimating renal plasma flow in unanesthetized rats. Maling HM; Saul W; Yasaka WJ; Gillette JR Proc Soc Exp Biol Med; 1979 May; 161(1):88-93. PubMed ID: 441077 [No Abstract] [Full Text] [Related]
75. Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease. Yü TF; Berger L Am J Med; 1982 Jan; 72(1):95-100. PubMed ID: 7058827 [TBL] [Abstract][Full Text] [Related]
76. Observations on three dosage forms of pindolol. Carruthers SG Am Heart J; 1982 Aug; 104(2 Pt 2):451-5. PubMed ID: 7102531 [No Abstract] [Full Text] [Related]
77. Long-term effects of pindolol on serum lipoproteins in hypertensive patients. Gretzer I; Rössner S Acta Med Scand; 1986; 219(4):367-70. PubMed ID: 3716878 [TBL] [Abstract][Full Text] [Related]
79. [Problems of total clearance methods. II. The interrelation of lowered plasma level, renal secretion, distribution and clearance of PAH after a single intravenous injection]. UHLMANN W Klin Wochenschr; 1955 Aug; 33(29-30):713-9. PubMed ID: 13264509 [No Abstract] [Full Text] [Related]
80. Oral pindolol in acute evolving myocardial infarction. O'Rourke MF; Baron D; Washington H; Sammel N; Le Cheminant D Aust N Z J Med; 1979 Aug; 9(4):408-11. PubMed ID: 41510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]